Lith-Oijen, Netherlands

Remon Van Geel

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 120(Granted Patents)


Location History:

  • Oss, NL (2016 - 2020)
  • CM Lithoijen, NL (2022)
  • Lith-Oijen, NL (2018 - 2023)
  • Lithoijen, NL (2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Remon Van Geel in Antibody Research**

Introduction

Remon Van Geel, an esteemed inventor based in Lith-Oijen, Netherlands, has made significant contributions to the field of antibody research. With a remarkable portfolio of 13 patents, he is recognized for his innovative approaches in bioconjugation techniques and glycoprotein modification.

Latest Patents

Among Van Geel's latest patents is a groundbreaking invention involving modified antibodies and antibody-conjugates. This patent focuses on an antibody comprising a GlcNAc-S(A) substituent, where S(A) represents a sugar derivative that can possess various functional groups. The versatility of this innovation is demonstrated through its potential applications in developing antibody-conjugates employed as medicaments. Furthermore, his process for modifying glycoproteins utilizes a glycosyltransferase, which enhances the functionality of the glycoproteins by enabling the enzymatic modification in the presence of non-natural sugar-derivative nucleotides. These inventions highlight Van Geel's commitment to advancing therapeutic applications in immunology.

Career Highlights

As a prominent figure at Synaffix B.V., Van Geel's work focuses on pioneering new methodologies in antibody-drug conjugates and advancing the field of targeted therapies. His dedication to research and innovation has made a significant impact on the development of novel medical treatments, showcasing his expertise in crafting superior bioconjugates.

Collaborations

Throughout his career, Remon Van Geel has collaborated with esteemed colleagues such as Floris Louis Van Delft and Maria Antonia Wijdeven. These professional partnerships have fostered an environment of creativity and excellence, allowing for the exchange of ideas and expertise in their joint efforts to push the boundaries of current scientific understanding.

Conclusion

In summary, Remon Van Geel epitomizes the spirit of innovation within the scientific community. His extensive work on modified antibodies and glycoprotein processes represents a leap forward in medical science, potentially paving the way for new therapeutic options. Through his collaborations and continued research, Van Geel remains a pivotal force in the realm of bioconjugation and immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…